Literature DB >> 18521049

Beyond frequency: who is most bothered by vasomotor symptoms?

Rebecca C Thurston1, Joyce T Bromberger, Hadine Joffe, Nancy E Avis, Rachel Hess, Carolyn J Crandall, Yuefang Chang, Robin Green, Karen A Matthews.   

Abstract

OBJECTIVE: Most menopausal women report vasomotor symptoms (hot flashes, night sweats). However, not all women with vasomotor symptoms, including frequent symptoms, are bothered by them. The primary aim was to identify correlates of vasomotor symptom bother beyond symptom frequency.
DESIGN: The Study of Women's Health Across the Nation participants reporting vasomotor symptoms at annual visit 7 comprised the sample (N = 1,042). Assessments included hot flash and night sweats frequency (number per week) and bother (1, not at all- 4, very much). Negative affect (index of depressive symptoms, anxiety, perceived stress, negative mood), symptom sensitivity, sleep problems, and vasomotor symptom duration (number of years) were examined cross-sectionally in relation to bother in ordinal logistic regression models with symptom frequency and covariates. Hot flashes and night sweats were considered separately.
RESULTS: In multivariable models controlling for hot flash frequency, negative affect (odds ratio [OR] = 1.27, 95% CI: 1.08-1.51), symptom sensitivity (OR = 1.18, 95% CI: 1.03-1.37), sleep problems (OR = 1.38, 95% CI: 1.04-1.85), poorer health (OR = 1.24, 95% CI: 1.03-1.48), duration of hot flashes (OR = 1.14, 95% CI: 1.06-1.23), younger age (OR = 0.94, 95% CI: 0.89-0.99), and African American race (vs white, OR = 1.59, 95% CI: 1.12-2.26) were associated with hot flash bother. After controlling for night sweats frequency and covariates, sleep problems (OR = 1.84, 95% CI:1.33-2.55) and night sweats duration (OR = 1.10, 95% CI: 1.02-1.20) were associated with night sweats bother.
CONCLUSIONS: Beyond frequency, factors associated with bothersome hot flashes include mood, symptom sensitivity, symptom duration, sleep problems, age, and race. Correlates of bothersome night sweats include sleep problems and symptom duration. In addition to reducing frequency, interventions for vasomotor symptoms might consider addressing modifiable factors related to symptom bother.

Entities:  

Mesh:

Year:  2008        PMID: 18521049      PMCID: PMC2866103          DOI: 10.1097/gme.0b013e318168f09b

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  37 in total

1.  Menopausal symptoms in older women and the effects of treatment with hormone therapy.

Authors:  Vanessa M Barnabei; Deborah Grady; Dale W Stovall; Jane A Cauley; Feng Lin; Cynthia A Stuenkel; Marcia L Stefanick; James H Pickar
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Methodologic lessons learned from hot flash studies.

Authors:  J A Sloan; C L Loprinzi; P J Novotny; D L Barton; B I Lavasseur; H Windschitl
Journal:  J Clin Oncol       Date:  2001-12-01       Impact factor: 44.544

3.  Ethnic differences in pain tolerance: clinical implications in a chronic pain population.

Authors:  R R Edwards; D M Doleys; R B Fillingim; D Lowery
Journal:  Psychosom Med       Date:  2001 Mar-Apr       Impact factor: 4.312

Review 4.  Pain and emotion: new research directions.

Authors:  F J Keefe; M Lumley; T Anderson; T Lynch; J L Studts; K L Carson
Journal:  J Clin Psychol       Date:  2001-04

5.  Evaluation of the kaiser physical activity survey in women.

Authors:  B E Ainsworth; B Sternfeld; M T Richardson; K Jackson
Journal:  Med Sci Sports Exerc       Date:  2000-07       Impact factor: 5.411

6.  Relationships between catastrophic thoughts, perceived control and distress during menopausal hot flushes: exploring the correlates of a questionnaire measure.

Authors:  F Reynolds
Journal:  Maturitas       Date:  2000-08-31       Impact factor: 4.342

7.  Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.

Authors:  Vered Stearns; Katherine L Beebe; Malini Iyengar; Eric Dube
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

8.  Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition.

Authors:  Howard M Kravitz; Patricia A Ganz; Joyce Bromberger; Lynda H Powell; Kim Sutton-Tyrrell; Peter M Meyer
Journal:  Menopause       Date:  2003 Jan-Feb       Impact factor: 2.953

9.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

Review 10.  Psychoeducational interventions to alleviate hot flashes: a systematic review.

Authors:  Anouk Tremblay; Lisa Sheeran; Sanchia K Aranda
Journal:  Menopause       Date:  2008 Jan-Feb       Impact factor: 2.953

View more
  57 in total

1.  Sisters Peer Counseling in Reproductive Issues After Treatment (SPIRIT): a peer counseling program to improve reproductive health among African American breast cancer survivors.

Authors:  Leslie R Schover; Michelle M Rhodes; George Baum; Jennifer Harned Adams; Rosell Jenkins; Pamela Lewis; Karen Eubanks Jackson
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

2.  The impact of menopause on health-related quality of life: results from the STRIDE longitudinal study.

Authors:  Rachel Hess; Rebecca C Thurston; Ron D Hays; Chung-Chou H Chang; Stacey N Dillon; Roberta B Ness; Cindy L Bryce; Wishwa N Kapoor; Karen A Matthews
Journal:  Qual Life Res       Date:  2011-07-14       Impact factor: 4.147

Review 3.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

4.  Relationships between menopausal and mood symptoms and EEG sleep measures in a multi-ethnic sample of middle-aged women: the SWAN sleep study.

Authors:  Howard M Kravitz; Elizabeth Avery; Maryfran Sowers; Joyce T Bromberger; Jane F Owens; Karen A Matthews; Martica Hall; Huiyong Zheng; Ellen B Gold; Daniel J Buysse
Journal:  Sleep       Date:  2011-09-01       Impact factor: 5.849

5.  Phytoestrogen and fiber intakes in relation to incident vasomotor symptoms: results from the Study of Women's Health Across the Nation.

Authors:  Ellen B Gold; Katherine Leung; Sybil L Crawford; Mei-Hua Huang; L Elaine Waetjen; Gail A Greendale
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

6.  Improving the performance of physiologic hot flash measures with support vector machines.

Authors:  Rebecca C Thurston; Karen A Matthews; Javier Hernandez; Fernando De La Torre
Journal:  Psychophysiology       Date:  2009-01-26       Impact factor: 4.016

Review 7.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

8.  The association of an alpha2C adrenoreceptor gene polymorphism with vasomotor symptoms in African American women.

Authors:  Devora A Aharon; Elissa Gretz Friedman; Jessica R Overbey; Maryann McLaughlin; Taimour Langaee; Rebecca C Thurston
Journal:  Menopause       Date:  2019-03       Impact factor: 2.953

9.  Depression, quality of life, work productivity, resource use, and costs among women experiencing menopause and hot flashes: a cross-sectional study.

Authors:  Marco Dacosta Dibonaventura; Jan-Samuel Wagner; Jose Alvir; Jennifer Whiteley
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-01

10.  Associations of Intimate Partner Violence, Sexual Assault, and Posttraumatic Stress Disorder With Menopause Symptoms Among Midlife and Older Women.

Authors:  Carolyn J Gibson; Alison J Huang; Brigid McCaw; Leslee L Subak; David H Thom; Stephen K Van Den Eeden
Journal:  JAMA Intern Med       Date:  2019-01-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.